EU

Make sure patients know how long to self treat, says PAGB

16 Nov 12 | 14.11 | EU

Pharmacists should make sure people know how long to self treat coughs and colds before visiting their GP...
more >
Use black triangle for implants with limited data

1 Nov 12 | 13.34 | England EU Northern Ireland Scotland Wales

Reporting of adverse incidents relating to medical implants should be made mandatory for healthcare professionals...
more >
International group calls for more rigour in clinical research

29 Oct 12 | 13.32 | EU International

Clinical researchers need to work harder to ensure their studies have sound methodologies and do not repeat work...
more >
Higher heart risk with diclofenac than other NSAIDs

23 Oct 12 | 14.53 | EU

Diclofenac is associated with a "consistent but small" increase in the risk of cardiovascular side effects...
more >
Pandemrix-narcolepsy data review raises no fresh concerns

22 Oct 12 | 16.40 | EU

The CHMP reviewed two Finnish studies (PJ 2012;288:405) linking GlaxoSmithKline’s Pandemrix vaccine with an increased narcolepsy risk in children.
more >
Safety of codeine for children after surgery goes under review

8 Oct 12 | 15.01 | EU

A safety review of the use of codeine-containing medicines for relieving children’s pain after surgery has been launched...
more >
Patient-focused health app launched

3 Oct 12 | 14.54 | EU

A European directory of 200 organisations that are useful to patient groups has been launched as a free smart phone application... more >
Cardiovascular section of paediatric drugs inventory out for consultation

7 Sep 12 | 14.40 | EU

A list of all cardiovascular medicines that are used in children, compiled by the European Medicines Agency, is out for public consultation...
more >
Counterfeit medicines biggest EU customs haul of 2011

13 Aug 12 | 12.04 | EU International

Community pharmacists have called on the Government to work with the industry to strengthen protection against counterfeit medicines...
more >
Glybera first gene therapy to gain EMA approval

26 Jul 12 | 11.41 | EU

Alipogene tiparvovec has become the first gene therapy to be recommended for approval by the European Medicines Agency...
more >